Trials / Completed
CompletedNCT03479099
Liquid Biopsy in Lung Cancer
Clinical Utility of Combined CTC and ctDNA Assay in the Diagnosis of Primary Lung Cancer
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 111 (actual)
- Sponsor
- Samsung Medical Center · Academic / Other
- Sex
- All
- Age
- 18 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to assess clinical utility of combined circulating tumor cell (CTC) and circulating tumor DNA (ctDNA) in the diagnosis of primary lung cancer.
Detailed description
The peripheral blood and tumor tissue samples are collected from the participants.CTC and ctDNA are analyzed from the blood samples.
Conditions
Timeline
- Start date
- 2018-03-12
- Primary completion
- 2019-03-11
- Completion
- 2019-03-11
- First posted
- 2018-03-27
- Last updated
- 2019-08-28
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT03479099. Inclusion in this directory is not an endorsement.